Emerging Pathways in Antipsychotic Drug Development: A MindLabs Psychosis Webinar
Event description
Mindgardens is pleased to present the second edition of the MindLabs Psychosis Webinar series for 2026, Beyond D2: Emerging Pathways in Antipsychotic Drug Development, presented by Dr Samuel Dearness.
Speaker
Dr Samuel Dearness is a RANZCP psychiatry trainee who is approaching the end of his training in the South Eastern Sydney Local Health District (SESLHD). He has undertaken advanced training across multiple speciality services including the Tertiary Referral Service for Psychosis (TRSP), Neuropsychiatric Institute and the SESLHD Specialised Intellectual Disability Health Team, gaining experience in complex neuropsychiatric presentations across inpatient and community settings. Samuel completed his early medical and psychiatry training in rural and regional Australia, fostering a strong commitment to addressing health inequities and improving access to high-level specialist care for underserved populations. His has a strong commitment to improving the care of people living with neuropsychiatric illness, intellectual disability and neurodivergence with a focus on integrated, holistic healthcare. Recently, Samuel had been the trainee representative in the RANZCP neuropsychiatry advanced training working group and is motivated to contribute to the development of neuropsychiatry as a subspecialty in Australia.
Learning Outcomes
By the end of this webinar, attendees will:
- Gain an understanding of the history of schizophrenia and “dopamine hypothesis”.
- Gain an understanding of the cholinergic dysfunction in psychosis, with specific reference to muscarinic M1 and M4 receptor pathways and their relevance to positive, negative, and cognitive symptoms of schizophrenia
- Gain insight into the potential clinical role of novel, non-dopaminergic antipsychotics, including considerations for treatment-resistant populations
- Gain insight into emerging therapeutic targets in schizophrenia and discuss future directions for antipsychotic development, with particular attention to negative symptoms and cognition
Latest News & Events
Keeping the Co in Co-Design: A MindLabs Workshop
February 6, 2026This workshop is for people who are interested in understanding and incorporating multiple perspectives and goals into projects.
Emerging Pathways in Antipsychotic Drug Development: A MindLabs Psychosis Webinar
February 6, 2026Second edition of the MindLabs Psychosis Webinar series for 2026, presented by Dr Samuel Dearness, RANZCP psychiatry trainee , SESLHD.
Making Meaning of Physical Multimorbidity: A MindLabs Psychosis Webinar
February 6, 2026Mindgardens is pleased to present the first edition of the MindLabs Psychosis Webinar series for 2026, presented by Dr Sean Halstead.
Mindgardens Neuroscience Network acknowledges the Traditional Owners of Country throughout Australia and recognises their continuing connection to land, waters and community. We pay our respect to them and their cultures, and to Elders past, present and emerging.
We acknowledge the voices of people with lived experience, their carers, families and kinship groups. We recognise the expertise acquired through living with a mental health, drug and alcohol or neurological disorder and acknowledge those who care for people on their recovery journey. We place lived experience at the heart of all that we do.
Brings together the strengths of four founding organisations
